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Abstract
Although a critical role for caveolae-mediated albumin transcytosis in pulmonary endothelium is well established,
considerably less is known about caveolae-independent pathways. In this current study, we confirmed that cultured
rat pulmonary microvascular (RPMEC) and pulmonary artery (RPAEC) endothelium endocytosed Alexa488-labeled
albumin in a saturable, temperature-sensitive mode and internalization resulted in co-localization by fluorescence
microscopy with cholera B toxin and caveolin-1. Although siRNA to caveolin-1 (cav-1) in RPAEC significantly
inhibited albumin uptake, a remnant portion of albumin uptake was cav-1-independent, suggesting alternative
pathways for albumin uptake. Thus, we isolated and cultured mouse lung endothelial cells (MLEC) from wild type and
cav-1-/- mice and noted that ~ 65% of albumin uptake, as determined by confocal imaging or live cell total internal
reflectance fluorescence microscopy (TIRF), persisted in total absence of cav-1. Uptake of colloidal gold labeled
albumin was evaluated by electron microscopy and demonstrated that albumin uptake in MLEC from cav-1-/- mice
was through caveolae-independent pathway(s) including clathrin-coated pits that resulted in endosomal accumulation
of albumin. Finally, we noted that albumin uptake in RPMEC was in part sensitive to pharmacological agents
(amiloride [sodium transport inhibitor], Gö6976 [protein kinase C inhibitor], and cytochalasin D [inhibitor of actin
polymerization]) consistent with a macropinocytosis-like process. The amiloride sensitivity accounting for
macropinocytosis also exists in albumin uptake by both wild type and cav-1-/- MLEC. We conclude from these studies
that in addition to the well described caveolar-dependent pulmonary endothelial cell endocytosis of albumin, a portion
of overall uptake in pulmonary endothelial cells is cav-1 insensitive and appears to involve clathrin-mediated
endocytosis and macropinocytosis-like process.
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Introduction
Caveolae are flask-shaped membrane invaginations of the
plasma membrane and caveolin-1 (cav-1, a 22-kDa protein)
acts as the major structural protein and biochemical marker of
caveolae [1-3]. Caveolae have been implicated in many
biological processes such as endocytosis, transcytosis, and
cell signaling, and they are believed to play a major role in the
transport of albumin in endothelial cells. The process of
endocytosis and transcytosis is the result of fission and
trafficking of caveolae [4-9]. Caveolar (and cav-1) -dependent
transcytosis of albumin transport in lung endothelium is of both
historical [10–12] and physiological [8] significance as this
aspect of cell biology has advanced [9,13-16]. In particular,
from original gold-labeled albumin electron microscopy studies
in intact wild type animals [17,18] to more recent investigations
with similar technology in cav-1 null mice [19,20] as well as
efforts in isolated cultured lung endothelial cells [21,22], a
concensus has emerged regarding the importance of caveolae-
dependent transcytosis of albumin in the pulmonary
endothelium. The lack of uptake of gold-conjugated albumin in
the pulmonary microvascular endothelium of cav-1 null,
caveolae-deficient mice [14,19] underscores the role of
caveolae in this process. Nonetheless, in cav-1 null mice that
are devoid of caveolae, occasional invaginations with electron
dense diaphragms in large vessels of the lung were observed
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[19]. This could account for the minor fraction of gold-labeled
albumin that was taken up in fluid phase by endocytosis [18] or
the preliminary observations of caveolae-independent gold-
labeled albumin uptake in the lung by Predescu et al [23]. The
original observation of normal albumin transport in the choroid
plexus (ascribed to transcytosis) in cav-1 null mice [19] also
suggests possible caveolae-independent transport of albumin.
This latter observation is distinctly different from the
hyperpermeability of albumin in cav-1 null mice [24,25] that is
sensitive to nitric oxide synthase inhibitors and in which the role
of enhanced NO biosynthesis on paracellular pathways has
been elucidated in lung endothelium [21].
Accordingly, we pursued issues of caveolae-independent
transport of albumin in fixed and live cultured pulmonary
endothelium. Our ultimate focus on macropinocytosis
accounting for a portion of albumin uptake in pulmonary
endothelium was prompted by our recent observation that
another ligand, e.g. Duffy antigen receptor for chemokines
(DARC), for caveolae-dependent transcytosis of chemokines,
also displayed cav-1 independent endocytosis and had a
pharmacological profile consistent with macropinocytosis-
mediated uptake [26].
Materials and Methods
Cell Culture
Rat pulmonary microvascular endothelial cells (RPMEC)
were purchased from VEC Technologies (VEC Technologies,
Rensselaer, NY, USA) and cultured in MCDB-131 complete
medium (VEC Technologies). Rat pulmonary artery endothelial
cells (RPAEC), isolated [27] and donated by Dr. Troy Stevens
(University of South Alabama, Tuscaloosa, AL), were cultured
in Dulbecco’s Modified Eagle Medium (DMEM, Life
Technologies, Carlsbad, CA, USA) supplemented with 10%
fetal bovine serum (FBS, Life Technologies, Carlsbad, CA,
USA), 100 U/ml penicillin and 100 µg/ml streptomycin (Life
Technologies, Carlsbad, CA, USA). RPMEC and RPAEC were
incubated at 37°C in humidified atmosphere with 21% O2 and
5% CO2. Mouse lung endothelial cells (MLEC) were isolated
from wild type or caveolin-1 (cav-1) null mice [28] by
immunobeads coated with anti-mouse PECAM (CD31)
antibody (BD Pharmingen, San Diego, CA, USA) followed by
cell sorting with fluorescently-labeled acetylated-Low Density
Lipoprotein (Dil-AcLDL, Biomedical Technologies Inc.,
Stoughton, MA, USA) uptake. MLEC were subcultured at 37°C
in humidified atmosphere with 2% O2 and 5% CO2 in OPTI-
MEM (Life Technologies, Carlsbad, CA, USA) supplemented
with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and
EC growth supplement (ENDOGRO, VEC Technologies) as
previously described [29]. MLEC were studied before passage
7 and were virtually (98-100%) homogeneously positive for
PECAM and uptake of Dil-AcLDL. Animal care and use were
carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the
Committee on the Ethics of Animal Experiments of the
University of Pittsburgh (Protocol Number: 1111998). Mouse
sacrifice was performed under anesthesia and all efforts were
made to minimize suffering.
Alexa488-BSA Uptake
Cells were plated into Lab-Tek II 4-well chamber slides
(Nalge Nunc, Naperville, IL, USA) and grown until 90%
confluent. After serum starvation for 4 h, cells were incubated
with 50 μg/ml of Alexa488-BSA (Life Technologies, Carlsbad,
CA, USA) in HBSS for indicated time at 37°C. Cells were fixed
with 2% paraformaldehyde and stained with DAPI (Life
Technologies, Carlsbad, CA, USA) to reveal cell nuclei and
then slides were peeled off and sealed with Fluoromount-G
(Southern Biotechnology Associates, Birmingham, AL, USA)
under coverslips. Images were taken with Nikon Eclipse 80i
fluorescence microscope (Nikon, Melville, NY, USA) and a
Fluoview 500 confocal Microscope (Olympus, Center Valley,
PA, USA).
Immunofluorescent staining of cav-1
After incubating with Alexa488-BSA and washing with HBSS,
cells were fixed with 2% paraformaldehyde for 15 min at room
temperature and then permeabilized with 0.1% Triton X-100
(Sigma-Aldrich, St Louis, MO, USA) for 15 min. Blocking was
performed with 20% goat serum (Sigma-Aldrich, St Louis, MO,
USA) in PBS containing 0.5% BSA (Fraction V, Roche,
Mannheim, Germany) for 1 h, then cells were incubated with
anti-cav-1 primary polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) for 1 h followed by 1 h
incubation with Cy3-conjugated secondary antibody (Jackson
ImmunoResearch, West Grove, PA, USA). Cell nuclei were
stained with DAPI (Life Technologies, Carlsbad, CA, USA) and
coverslips were sealed on slides. Images were taken with
Nikon Eclipse 80i fluorescence microscope and an Olympus
Fluoview 500 confocal Microscope.
Cav-1 knockdown with siRNA
Small interfering RNA (siRNA) was designed against the
coding sequence of cav-1 cDNA
(AAGAGCTTCCTGATTGAGATT) and both siRNA and sham
siRNA (with scrambled sequence) were purchased from
Dharmacon (Chicago, IL, USA). Transfection of siRNA (100
nM) into RPAEC was carried out by using Lipofectamine 2000
(Life Technologies, Carlsbad, CA, USA) and 72 h later
Alexa488-BSA endocytosis and immunofluorescent staining of
cav-1 were performed.
Immunoblot of cav-1
Cells were washed three times with ice-cold PBS, and then
lysed on ice in SDS sample buffer (62.5 mM Tris-HCl, pH 6.8,
2% w/v SDS, 10% glycerol, 50 mM DTT, 0.01% w/v
bromophenol blue). The extracts were sonicated briefly, boiled
for 5 min, then centrifuged at 14,000 rpm for 5 min. Equivalent
amounts of protein were separated by electrophoresis using
10% SDS-PAGE gels. The proteins were then transferred to
PVDF membrane (Life Technologies, Carlsbad, CA, USA) and
blocked with PBS containing 5% nonfat milk for 1 h at RT.
Membranes were incubated with primary antibody against
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cav-1 (BD Pharmingen, San Diego, CA, USA) overnight at 4°C
and HRP-conjugated secondary antibody (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) was used for
visualization by chemiluminescence using ECL reagent
(Perkin-Elmer Life Science, Boston, MA, USA). Blots were
stripped with stripping buffer (Pierce, Rockford, IL, USA) and
reprobed with antibody against β-actin (Sigma-Aldrich, St
Louis, MO, USA).
Transmission electron microscopy
Bovine serum albumin (BSA, Roche, Mannheim, Germany)
was conjugated to colloidal gold particles (5 nm) as described
by Baschong and Wrigley [30]. Unconjugated colloidal gold
were removed by centrifugation (45,000 × g for 15 min at 4°C)
of protein-gold complex, and the soft pellet was resuspended in
low-salt buffer (10 mM HEPES, 1 mM KCl, 0.5 mM MgCl2, pH
7.5). Cells were plated into 6-well plate and grown until
confluent. After serum starvation for 4 h, cells were moved to
4°C for 20 min, then incubated with Gold-labeled BSA in cold
HBSS for 40 min. Cells were fixed and embedded by inverting
Polybed 812-filled Better Equipment for Electron Microscopy
(BEEM) capsules on top of the cells. Blocks were cured
overnight at 37°C, and then cured for two days at 65°C.
Monolayers were pulled off the plastic and re-embedded for
cross-sectioning. Ultrathin cross-sections (60 nm) of the cells
were obtained on a Riechert Ultracut E microtome, post-
stained in 4% uranyl acetate for 10 min and 1% lead citrate for
7 min. Sections were viewed on a JEM 1011 transmission
electron microscope (JEOL, Peabody, MA, USA) at 80 KV.
Images were acquired with a side-mount AMT 2K digital
camera (Advanced Microscopy Techniques, Danvers, MA,
USA).
Total Internal Reflection Fluorescence (TIRF)
Microscopy
TIRF imaging was performed as described [31]. Cells were
imaged on a Nikon (Melville, NY, USA) TIRF system using a
60x (1.45 NA) optic and a Prairie (Madison, WI, USA) acousto-
optic tunable filter controlled laser bench. All experiments used
the 488 line on a 150-milliwatt argon source. Images were
collected using MetaMorph software (Molecular Devices,
Sunnyvale, CA) and a Orca II ER camera (Hamamatsu, Tokyo,
Japan). Time-based series were collected and processed using
MeatMorph.
Protocol for macropinocytosis study
Inhibitors of macropinocytosis (Amiloride, Cytochalasin D
and Gö6976) were purchased from Sigma-Aldrich (St Louis,
MO, USA). RPMEC were serum starved for 4 h followed by
pretreatment with amiloride (Na/H exchange inhibitor, 3 mM),
Cytochalasin D (actin polymerization inhibitor, 10 µM), and
Gö6976 (PKC inhibitor, 10 µM) for 30 min, then cells were
incubated with Alexa488-BSA (50 µg/ml) for 15 min and fixed
for imaging.
Image quantification and statistical analysis
Image quantification was performed with Imaris software
(Bitplane Inc, South Windsor, CT). Images were thresholded
and the spots function was used to define and quantify the
regions of albumin uptake within the cells. Data are present as
mean ± SEM. Statistical significance differences (* P < 0.05, **
P < 0.01, *** P < 0.001) were determined by t-test or one-way
analysis of variance (ANOVA) followed by Tukey's multiple
comparisons using Graphpad Prism ver. 5.0 (GraphPad
Software, San Diego, CA, USA).
Results
Albumin endocytosis in rat pulmonary endothelial cells
is a competitive, temperature sensitive and caveolae-
dependent process
To study the capability of rat pulmonary microvascular
endothelial cells (RPMEC) to uptake Alexa488-BSA, RPMEC
were incubated with Alexa488-BSA (50 μg/ml) from 0 min to 30
min. Uptake was apparent at the first time point (1 min) and
reached a plateau from 15-30 min (Figure 1A). A linear change
of Alexa488-BSA uptake was obtained in presence of small
concentrations (0.5 mg/ml - 5 mg/ml) of extracellular unlabeled
BSA while almost undetectable signals were found under
continuously increasing extracellular unlabeled BSA (10 mg/ml
- 50 mg/ml), suggesting a competitive process occurs in
albumin endocytosis (Figure 1B). Moreover, maintaining
temperature at 4°C virtually eliminated Alexa488-BSA uptake
(Figure 1C). After uptake, we noted (Figure 1D) significant co-
localization of Alexa488-BSA and Alexa555-cholera toxin
subunit B (CTB), a marker of caveolae, consistent with
previous reports [32] regarding the role of caveolae in albumin
uptake in pulmonary endothelial cells. After confirming (data
not shown) that RPAEC manifested similar features of albumin
uptake as did RPMEC, we knocked down cav-1 in RPAEC
using siRNA since they are more efficiently transfected than
RPMEC.
We note that siRNA to cav-1 greatly reduced, but did not
completely eliminate, immunoreactive cav-1 as detected by
Western blot (Figure 2A) or immunofluorescence (Figure 2B).
Uptake of non-saturating amounts of Alexa488-BSA was
readily apparent in wild type or sham siRNA treated RPAEC
but was greatly, but not completely, reduced (42.4 ± 2.9%
persistent) in RPAEC treated with siRNA to cav-1. Alexa488-
BSA co-localized with immunoreactive cav-1 in wild type and
sham siRNA treated (Figure 2B). Nonetheless, because
knockdown of cav-1 was incomplete (Figure 2A), it was
ambiguous to credit the residual uptake of Alexa488-BSA to a
caveolae-independent process and accordingly, we isolated
and cultured mouse lung endothelial cells (MLEC) from wild
type and cav-1 null mice.
Caveolae-independent albumin endocytosis presents in
pulmonary endothelial cells
In contrast to wild type MLEC, MLEC from cav-1-/- mice had
no detectable cav-1 (Figure 3A). Similar to our experience with
RPAEC (see above), there was significant uptake of Alexa488
BSA, by both widefield fluorescence (Figure 3B) and confocal
Albumin Endocytosis in Pulmonary Endothelium
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Figure 1.  Albumin endocytosis is a competitive, temperature sensitive, and caveolae-associated process in pulmonary
endothelial cells.  (A) Time course of Alexa488-BSA endocytosis in rat pulmonary microvascular endothelial cells (RPMEC). Cells
were serum starved and then incubated with Alexa488-BSA (50 µg/ml) for 0 to 30 min at 37°C. Images were taken by confocal
microscopy (Olympus Fluoview 1000) at 60× (1.42 NA) magnification with 2X zoom. Representative fluorescence intensity analysis
was determined by quantifying fluorescent intensity of 20-30 cells in 5 random fields using Imaris software. Values are mean ± SEM
from 5 separate fields in each condition. Significant differences from control (*** P < 0.001) were determined by one-way ANOVA
followed by Tukey's multiple comparisons. (B) Endocytosis of Alexa488-BSA by RPMEC was reduced by increasing extracellular
concentrations (0.5 mg/ml - 50 mg/ml) of unlabeled BSA. Cells were serum starved for 4 h then incubated with Alexa488-BSA (50
µg/ml) in the presence of indicated concentrations of unlabeled BSA for 20 min at 37°C. Images were taken by fluorescent
microscopy at 20× magnification. Representative fluorescence intensity analysis was determined by quantifying fluorescent intensity
of 20-30 cells in random 5 fields with Imaris software. Values are mean ± SEM from 5 separate fields in each condition. (C)
Alexa488-BSA endocytosis in RPMEC is temperature sensitive. Cells were incubated with Alexa488-BSA (50 µg/ml) in the presence
of unlabeled BSA (0.5 mg/ml) for 20 min at 4°C and 37°C, respectively. Images were taken by confocal microscopy (60×
magnification). Representative images of three independent experiments are shown. (D) Alexa488-BSA (green) is co-localized with
Alexa555-cholera toxin subunit B (CTB, red) in RPMEC. Cells were incubated with Alexa488-BSA (50 µg/ml) and Alexa555-CTB (20
µg/ml) in HBSS containing unlabeled BSA (0.5 mg/ml) for 30 min at 37°C, cells were then washed, fixed and visualized by confocal
microscopy after mounting.
doi: 10.1371/journal.pone.0081903.g001
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Figure 2.  Caveolin-1 RNAi reduced Alexa488-BSA endocytosis in pulmonary artery endothelial cells.  (A) Representative
immunoblot of cav-1 expression in RPAEC treated with transfection reagent only, sham siRNA, and cav-1 siRNA is shown with β-
actin as loading control. Densitometric measurement was determined by NIH Image J software. Values are mean ± SEM. Significant
difference from control (** P < 0.01) was determined by one-way ANOVA followed by Tukey's multiple comparisons. (B) Alexa488-
BSA endocytosis was reduced by siRNA to cav-1 in RPAEC. siRNA to cav-1 (100 nM) and sham siRNA (100 nM) were transfected
into RPAEC with Lipofectamine 2000. After 72 h, the cells were incubated with Alexa488-BSA (50 µg/ml) for 30 min at 37°C and
then fixed in 2% paraformaldehyde followed by immunofluorescence staining for cav-1. Representative confocal images (60×
magnification) of three independent experiments are shown. (C) Representative fluorescence intensity analysis was determined by
quantifying fluorescent intensity of 20-30 cells in 5 random fields with Imaris software. Values are mean ± SEM from 5 separate
fields in each condition. Significant difference from control (** P < 0.01) was determined by student’s t test.
doi: 10.1371/journal.pone.0081903.g002
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(Figure 3C) microscopy in wild type MLEC. As in RPAEC
treated with siRNA to cav-1, cav-1-/- MLEC appeared to have a
persistent remnant (65.1 ± 8.1%) of Alex488-BSA uptake
compared to wild type cells (Figures 3B and 3C). To better
quantify such cav-1-independent uptake, we studied the
disposition of Alex488-BSA in live MLEC by TIRF (Figure 4A).
Alexa488-BSA was incubated with each cell type and
fluorescence signals (FITC, green) were recorded for 30 min.
Although overall uptake (e.g. net fluorescence via TIRF) was
greater in wild type than cav-1-/- MLEC, there was still readily
detectable uptake in null cells at each time point and the overall
rate of uptake was comparable between the two cell types
(Figure 4B).
In addition, we compared the uptake of gold-labeled albumin
in cav-1+/+ MLEC with that of cav-1-/- MLEC by using
transmission electron microscopy. Although cav-1-/- MLEC lack
classical “Ω” shape caveolae vesicles, there was detectable
transport of gold-labeled albumin through caveolae-
independent process including clathrin-coated pits by 40
minutes, and electron dense material was associated with
endosomes; Interestingly, in addition to caveolae-mediated
albumin uptake, we also observed clathrin-mediated albumin
transport in cav-1+/+ MLEC (Figure 5).
Macropinocytosis is involved in albumin endocytosis in
pulmonary endothelial cells
The dispensability of cav-1 for at least a portion of albumin
uptake was reminiscent of our recent experience with another
ligand, Duffy antigen receptor for chemokine, and its role in
chemokine internalization and transport across endothelium,
previously assumed to involve a process of caveolar-
dependent transcytosis [26]. Accordingly, we tested the drug
sensitivity of a potential macropinocytic pathway and noted that
uptake of Alexa488-BSA in RPMEC was significantly
decreased by amiloride (inhibitor of Na/H exchange) and
Gö6976, a protein kinase C inhibitor. In addition, cytochalasin
D, an actin polymerization inhibitor also reduced uptake (Figure
6). We confirmed that albumin uptake was amiloride sensitive
in both cav-1+/+ and cav-1-/- MLEC since 70% of albumin uptake
was reduced in cav-1-/- cells while only 50% reduced in cav-1+/+
cells (data not shown). Collectively these data are consistent
with macropinocytosis-like process accounting for a portion of
albumin uptake in both rat and mouse endothelium.
Discussion
Transcytosis, or the transport of molecules across cells, is a
fundamental aspect of cell biology and maintains tissue
homeostasis and normal organ function [9]. From a historical
and physiological basis, transcellular transport of albumin
across pulmonary endothelium has been one of the most
studied of such systems. In particular, initial studies with gold-
labeled albumin and transmission electron microscopy in the
pulmonary circulation suggested a dynamic process that
coupled endocytosis to exocytosis and potential directional
movement of macromolecules [17] leading Simionescu and
colleagues to coin the term transcytosis. Further structural and
functional studies led to identification of the role of caveolae
(and cav-1) in this process and ultimately led several groups
[19,33,34] to genetically ablate cav-1. Their collective
experience in these cav-1 knock out mice clearly demonstrated
a lack of caveolae biogenesis and an association with greatly
depressed accumulation of albumin. The compensatory
hyperpermeability to albumin in cav-1 null mice has been
ascribed to increased NO biosynthesis and the molecular
details accounting for increased paracellular transport in the
absence of transcytosis have been delineated in vivo
[24,25,35] and in cell culture [21]. As such, pulmonary
endothelium has been a useful prototype to advance
fundamental aspects of cell biology and contribute to the
ongoing debate [36] of relative contributions of transcytosis
[9,37] and paracellular [38] pathways or both [39] to
determinants of vascular permeability. Further molecular
details of the roles of dynamin, Rac and actin in co-regulation
of transcytosis and paracellular transport were recently
described in cultured human microvascular endothelium of
dermal origin [40] which is an extension of critical roles of
dynamin and actin cross-linking protein Filamin A in albumin
uptake demonstrated previously although this likely does not
distinguish caveolae- from clathrin-mediated endocytosis
[22,41].
Considerably less is known regarding cav-1-independent
pathways [9]. From the original report of Drab et al [19], there
were descriptions of invaginations with electron dense
diaphragms within endothelium of large vessels of cav-1 null
mice and a persistent uptake of albumin in the choroid plexus.
In this latter instance, albumin uptake has been proposed to be
a caveolae-dependent process [42] as it is in cultured
astrocytes [43]. A preliminary study indicated that vesicular
structures within endothelium, but without cav-1 (or clathrin)
coats, may be capable of functioning in transport of gold
albumin [23]. More recently [44], knockdown of a critical
adapter/scaffold protein, Intersectin-1s, led to impaired
biogenesis of caveolae and upregulation of a potential
alternative endocytic pathway in pulmonary endothelial
handling of gold labeled albumin. Whether cav-1-independent
vesiculo-vacuolar organelles in systemic venules are important
in transcytosis is also unclear. They persist, however, in the
cav-1 null mouse [45]. Several studies have noted that siRNA
to cav-1 treatment of cultured endothelium or astrocytes results
in partial decreases in albumin uptake (approximately 50-60%).
Silencing of cav-1 was not complete [43,46] and thus the
possibility of a coexisting alternative pathway remained
ambiguous. This is somewhat reminiscent of observations in
the current study in which albumin uptake (and cav-1) was only
partially inhibited in cav-1 siRNA treated cells (Figure 2A and
2B). Indeed such ambiguity prompted us to move from rat to
mouse lung endothelial cells that were subcultured from cav-1
null mice. With ambiguities of partial depletion aside, we still
noted residual (~ 65%) cav-1 independent uptake of albumin.
This was apparent by epifluorescence and confocal microscopy
(Figure 3B and 3C) of fixed cells as well as via TIRF analysis in
live MLEC (Figure 4). In the latter case, the overall magnitude
of uptake was less in cav-1 null cells but the rate of uptake
appeared similar to that noted in wild type cells. Cav-1 null
MLEC took up gold-labeled albumin likely through cav-1-
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Figure 3.  Endocytosis of Alexa488-BSA occurs in cav-1-/- MLEC through a caveolae-independent pathway.  (A)
Representative immunoblot of cav-1 expression in cav-1+/+ and cav-1-/- MLEC is shown with β-actin as loading control. (B)
Fluorescent images and (C) confocal images of Alexa488-BSA (green) and cav-1 staining (red) in cav-1+/+ and cav-1-/- MLEC are
shown (60× magnification). Cells were serum starved for 4 h and incubated with Alexa488-BSA (50 µg/ml) in HBSS for 30 min at
37°C, then cells were fixed and staining of cav-1 was performed. Representative images of three independent experiments are
shown. (D) Fluorescence intensity analysis was determined by quantifying fluorescent intensity of 20-30 cells in 5 random fields with
Imaris software. Values are mean ± SEM from two independent experiments.
doi: 10.1371/journal.pone.0081903.g003
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independent pathway(s) including clathrin-mediated
endocytosis, and the disposition appeared to be in endosomes
(Figure 5).
A number of other more elemental insights into caveolae
(and clathrin)-independent transport have emerged. In
particular, cholera toxin binding (CTB) subunit, a traditional
biomarker of caveolae-dependent processes, utilized a cav-1
independent, uncoated tubular or ring shaped structure
containing GPI-anchored proteins and fluid phase markers that
mediated CTB uptake in wild type and cav-1 null mouse
embryonic fibroblasts [47]. A simian virus 40 activated
endocytic pathway in human hepatoma 7 (deficient in cav-1)
Figure 4.  Dynamic process of Alexa488-BSA endocytosis in cav-1+/+ and cav-1-/- MLEC.  (A) Cav-1+/+ and cav-1-/- MLEC were
serum starved for 4 h then incubated with Alexa488-BSA (50 µg/ml) in HBSS. Fluorescence signals were recorded from 0 min to 30
min under total internal reflection fluorescence (TIRF) microscopy. Images from indicated time points (1, 5, 10, 15 and 20 min) are
shown. (B) Quantitative analyses of Alexa488-BSA uptake in cav-1+/+ and cav-1-/- MLEC were performed with MetaMorph software
by measuring the fold change of fluorescence intensity compared to cav-1+/+ MLEC at 1 min after treatment.
doi: 10.1371/journal.pone.0081903.g004
Albumin Endocytosis in Pulmonary Endothelium
PLOS ONE | www.plosone.org 8 November 2013 | Volume 8 | Issue 11 | e81903
and embryonic fibroblasts from cav-1 null mice was described
that did not involve either clathrin-coated pit or caveolae [48].
Most relevant to the current study was our recent observation
that Duffy Antigen Receptor for Chemokines (DARC) mediates
chemokine endocytosis through a macropinocytosis-like,
caveolae-independent process in endothelial cells [26]. Even
though DARC co-localized to cav-1 and DARC-mediated
chemokine internalization was cholesterol sensitive,
internalization of 125I-CXCL1 was independent of cav-1 (and
clathrin and flotillin-1). A macropinocytosis-like process
appeared to account for such internalization and chemokine
transport. These results prompted us to determine if
macropinocytosis might contribute to uptake of another ligand,
albumin, in cultured endothelium. We noted that uptake of
Alexa488-BSA in RPMEC was significantly decreased by
amiloride (inhibitor of Na/H exchange), Gö6976 (protein kinase
C inhibitor), and cytochalasin D (actin polymerization inhibitor)
(Figure 6). Such a pharmacological profile is consistent with a
macropinocytosis-like pathway contributing to albumin uptake
in cultured rat pulmonary endothelium and may account for the
persistent uptake of albumin noted in the presence of siRNA to
cav-1 in RPAEC (Figure 2B) or in MLEC from cav-1 null mice
(Figure 3, 4, 5). It is possible that upregulation of this pathway
may have occurred secondary to cav-1 silencing as
Figure 5.  Endocytosis of gold-labeled albumin occurs in cav-1+/+ MLEC (a-d) through caveolae-dependent and -
independent pathways but only through caveolae-independent pathway in cav-1-/- MLEC (e-g).  Both caveolae vesicles (black
arrow) and clathrin-coated pits (black arrowhead) were positive for gold-labeled albumin (a-c) suggestive of internalization via a
non-caveolin-1 dependent endocytic mechanism in cav-1+/+ MLEC. Although cav-1-/- MLEC lack classical caveolae vesicles, there
was detectable transport of gold labeled albumin to endosome and clathrin-coated pits were involved in the process (e-g). Cells
were plated into a 6-well plate and grown until confluent. After serum starvation for 4 hr, cells were incubated with gold-labeled BSA
in cold HBSS and moved to 4°C for 1 hr followed by warming at 37°C for up to 40 min. Cells were fixed and images were taken by
transmission electron microscopy (80000× magnification).
doi: 10.1371/journal.pone.0081903.g005
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Figure 6.  Inhibition of macropinocytosis prevents Alexa488-BSA uptake by rat pulmonary endothelial cells.  (A) RPMEC
were serum starved for 4 h followed by pretreatment with various inhibitors of macropinocytosis for 30 min including amiloride (Na/H
exchange inhibitor, 3 mM), Cytochalasin D (actin polymerization inhibitor, 10 µM), Gö6976 (PKC inhibitor, 10 µM), then cells were
incubated with Alexa488-BSA (50 µg/ml) for 15 min and fixed with 2% paraformaldehyde for imaging. Images were taken by
confocal microscopy (40× magnification). Representative images from three independent experiments are shown. (B) The
fluorescence intensity was determined by Imaris software with data are present as mean ± SEM from three independent
experiments. Significant differences from control (** P < 0.01, *** P < 0.001) were determined by one-way ANOVA followed by
Tukey's multiple comparisons.
doi: 10.1371/journal.pone.0081903.g006
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pretreatment of amiloride depleted most (~70%) albumin
uptake in cav-1-/- MLEC (data not shown). Our results are
consistent with a study by Cheng et al with respect to
enhanced fluid phase endocytosis after cav-1 silencing [49]. In
addition, Muro et al [50] identified a novel endocytic
mechanism to regulate the internalization of anti-ICAM-1 and
anti-PECAM-1 conjugates by endothelial cells which is distinct
from caveolae-mediated uptake or clathrin-mediated
endocytosis. This CAM-mediated endocytotic process was
sensitive to amiloride and PKC inhbitors [50] and thus shared
features of macropinocytosis as we have described in our
current and previous [26] studies. We did not examine requisite
role of dynamin-2 and other signaling and cytoskeletal protein
dependencies that led Muro et al [50] to distinguish CAM-
mediated endocytosis from macropinoyctosis.
In the current study, we show that cultured rodent pulmonary
endothelium (rat and mouse, pulmonary arterial and
microvascular) transport albumin by cav-1-dependent and -
independent processes. In addition to the well documented
caveolae-associated transcytosis, at least secondary pathways
including macropinocytosis and clathrin-mediated endocytosis
are apparent in these cells. A macropinocytosis-like process
may be compensatory and reminiscent of cav-1-independent
fluid phase transport of CTB [47] or albumin [49]. It bears some
similarity to the macropinocytosis pathway noted by us for
DARC mediated chemokine transcytosis [26]. In transmission
electron microscopy/gold-labeled albumin studies, we noted
that albumin is initially delivered to endosomes in cav-1-/- MLEC
via cav-1-independent pathways involving clathrin (Figure 5)
which may partly explain why albumin uptake was not
completely eliminated (~30% remnant) by amiloride (inhibitor of
macropinocytosis) in cav-1-/- MLEC. It is not apparent whether
drug sensitive profile of macropinocytosis of albumin was
coupled to a shuttling and exocytotic egress. The contribution
of potential artifacts secondary to studying cultured endothelial
cells in a monolayer on plastic dishes makes it ultimately
important to determine the functional consequences of cav-1-
independent albumin uptake in vivo, and whether it contributes
to potential regional differences (large vs small vessel) and
organ (brain vs lung, etc) heterogeneity of albumin transport
[9,51] as well as affecting determinants of transvascular protein
transport [36,38].
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